Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
Prospective phase 2 trial of high- and intermediate-intensity myeloablative conditioning for cord...
October 23, 2026
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
00:00
--:--
High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Ver...
October 23, 2026
Share
High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Vera: A Meta-Analysis.
https://www.medspoke.co/channel_journal?id=683&tap_id=16144
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Compr...
October 23, 2026
Why are you reporting this TALK?
